Roche(US:RHHBY) Su Zhou Ri Bao·2025-12-05 00:34Group 1 - Roche Diagnostics is a global leader in the diagnostics field and has established its largest single investment project in China in Suzhou, which is the Asia-Pacific reagent and instrument production and R&D base. The annual output value of the Suzhou base is expected to reach 10 billion yuan [1] - The local government representatives expressed gratitude for Roche Diagnostics' investment in Suzhou, highlighting the city's commitment to new industrialization and the integration of technology and industry innovation [1] - Roche Diagnostics has continuously increased its investment and launched a series of innovative products since its establishment in Suzhou, contributing to mutual success between the company and the local area [1] Group 2 - Rachel Klein, Global Operations President of Roche Diagnostics, expressed appreciation for the support from Suzhou and emphasized that Roche has become an indispensable part of the global layout of Roche Group over the past ten years [2] - The company is optimistic about the future development of Suzhou and plans to continue expanding its investment and accelerate the localization of R&D and production [2]